SE465462B - 6-brom-5-hydroxi-4-dimetylaminometyl-1-metyl-2-fenyltiometylindol-3-karbonsyra etylester-hydroklorid i monohydratform, foerfarande foer framstaellning av densamma och paa hydrokloriden i monohydratform baserat laekemedelspreparat med antivirusverkan interferoninducerande och immunomodulerande verkan - Google Patents

6-brom-5-hydroxi-4-dimetylaminometyl-1-metyl-2-fenyltiometylindol-3-karbonsyra etylester-hydroklorid i monohydratform, foerfarande foer framstaellning av densamma och paa hydrokloriden i monohydratform baserat laekemedelspreparat med antivirusverkan interferoninducerande och immunomodulerande verkan

Info

Publication number
SE465462B
SE465462B SE9000282A SE9000282A SE465462B SE 465462 B SE465462 B SE 465462B SE 9000282 A SE9000282 A SE 9000282A SE 9000282 A SE9000282 A SE 9000282A SE 465462 B SE465462 B SE 465462B
Authority
SE
Sweden
Prior art keywords
carboxylic acid
bromo
ethyl ester
methyl
preparation
Prior art date
Application number
SE9000282A
Other languages
English (en)
Swedish (sv)
Other versions
SE9000282D0 (sv
SE9000282L (sv
Inventor
A N Grinev
Original Assignee
Le Nii Epidemiolognauchno I I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Le Nii Epidemiolognauchno I I filed Critical Le Nii Epidemiolognauchno I I
Publication of SE9000282D0 publication Critical patent/SE9000282D0/xx
Publication of SE9000282L publication Critical patent/SE9000282L/xx
Publication of SE465462B publication Critical patent/SE465462B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9000282A 1989-01-12 1990-01-26 6-brom-5-hydroxi-4-dimetylaminometyl-1-metyl-2-fenyltiometylindol-3-karbonsyra etylester-hydroklorid i monohydratform, foerfarande foer framstaellning av densamma och paa hydrokloriden i monohydratform baserat laekemedelspreparat med antivirusverkan interferoninducerande och immunomodulerande verkan SE465462B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SU1988/000272 WO1990008135A1 (en) 1989-01-12 1989-01-12 Ethyl ester 6-bromine-5-hydroxy-4-dimethyl-aminomethyl-1-methyl-2-phenylthiomethyl indole-3-carboxylic acid hydrochloride monohydrate, method of obtaining it and a pharmaceutical preparation of antiviral, interferon inducing and immunomodulating action based on it

Publications (3)

Publication Number Publication Date
SE9000282D0 SE9000282D0 (sv) 1990-01-26
SE9000282L SE9000282L (sv) 1991-07-27
SE465462B true SE465462B (sv) 1991-09-16

Family

ID=21617367

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9000282A SE465462B (sv) 1989-01-12 1990-01-26 6-brom-5-hydroxi-4-dimetylaminometyl-1-metyl-2-fenyltiometylindol-3-karbonsyra etylester-hydroklorid i monohydratform, foerfarande foer framstaellning av densamma och paa hydrokloriden i monohydratform baserat laekemedelspreparat med antivirusverkan interferoninducerande och immunomodulerande verkan

Country Status (10)

Country Link
US (1) US5198552A (de)
BE (1) BE1003341A4 (de)
CH (1) CH678726A5 (de)
DE (2) DE3891468T1 (de)
DK (1) DK15490A (de)
FR (1) FR2650504B1 (de)
GB (1) GB2234510B (de)
NL (1) NL9000265A (de)
SE (1) SE465462B (de)
WO (1) WO1990008135A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3891468T1 (de) * 1989-01-12 1991-02-21 Vni Skij Chimiko Farmacevtices Aethylester der 6-brom-5-hydroxy-4-dimethylaminomethyl-1-methyl-2-phenylthiomethylindol-3-karbonsaeure des monohydrat-hydrogenchlorids, verfahren zu seiner herstellung und arzneipraeparat mit antiviraler, interferoniduzierender und immunomodulierender wirkung auf seiner grundlage
AU2395095A (en) 1994-04-29 1995-11-29 G.D. Searle & Co. Method of using (h+/k+) atpase inhibitors as antiviral agents
CN100361975C (zh) * 2003-01-04 2008-01-16 沈阳药科大学 5－羟基－3－羧酸酯吲哚类衍生物及其制备方法
CN1560035A (zh) * 2004-03-12 2005-01-05 沈阳药科大学 5－羟基吲哚－3－羧酸脂类衍生物
CN100519523C (zh) * 2004-03-12 2009-07-29 沈阳药科大学 5-羟基吲哚-3-羧酸酯类衍生物及其用途
CN100364975C (zh) * 2005-04-26 2008-01-30 武汉大学 一种抗呼吸道病毒的药物及用途
CN1316968C (zh) * 2005-09-30 2007-05-23 青岛大学 吲哚－2,3－二酮在制备抗病毒或免疫增强剂药物中的应用
US8329689B2 (en) 2006-05-23 2012-12-11 Alexandre Vasilievich Ivachtchenko Substituted indoles and a method for the production and use thereof
CN101070319B (zh) * 2007-05-29 2012-04-18 沈阳中海生物技术开发有限公司 一种抗乙肝病毒化合物的结晶形态以及它的制备方法和用途
CN103189354A (zh) 2010-07-16 2013-07-03 格林代克斯联合股份公司 具有抗病毒功效的1,4-二氢吡啶衍生物
CN102786461B (zh) * 2011-05-18 2016-08-31 中国医学科学院药物研究所 阿比朵尔盐酸盐晶e型及制法与在药品和保健品中应用
CN102786462B (zh) * 2011-05-18 2016-08-31 中国医学科学院药物研究所 阿比朵尔盐酸盐晶b型及制法与在药品和保健品中应用
CN102351778A (zh) * 2011-08-17 2012-02-15 湖北华龙生物制药有限公司 一种盐酸阿比朵尔的制备方法
EP2578218A1 (de) 2011-10-06 2013-04-10 Grindeks, A Joint Stock Company Antivirale Wirksamkeit von Dinatrium-2,6-Dimethyl-1,4-Dihydropyridin-3,5-Bis(carbonyloxyacetat) und Derivate davon
CN104193669B (zh) * 2014-08-01 2016-12-07 大连理工大学 一类阿比朵尔类似物或其盐、其制备方法及应用
CN106083691B (zh) * 2016-08-22 2018-11-27 山东罗欣药业集团恒欣药业有限公司 一种盐酸阿比朵尔一水合物的制备方法
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
CN111533677A (zh) * 2020-05-13 2020-08-14 大连万福制药有限公司 一种合成盐酸阿比朵尔中间体的方法
CN116003308B (zh) * 2022-12-27 2023-09-29 石家庄中硕制药有限公司 阿比多尔结晶方法
CN117586173B (zh) * 2023-11-29 2024-07-12 石家庄中硕制药有限公司 一种阿比多尔的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4124702A (en) * 1971-07-06 1978-11-07 Merck & Co., Inc. Polynucleotides active as inducers of interferon production in living animal cells
US4215137A (en) * 1978-06-26 1980-07-29 Sterling Drug Inc. Method of alleviating diseases by cell-mediated immune modulation
US4619942A (en) * 1982-04-08 1986-10-28 University Of North Carolina Inhibition of Respiratory Syncytial virus-induced cell fusion by amidino compounds
WO1987006227A2 (en) * 1986-04-17 1987-10-22 Jouhar Akbar Jan Indoloquinone compounds
EP0299076A4 (en) * 1987-01-23 1991-01-09 Yoshitomi Pharmaceutical Industries, Ltd. 5-hydroxyindole-3-carboxamide compound and medicinal use thereof
JPS63188665A (ja) * 1987-01-30 1988-08-04 Yoshitomi Pharmaceut Ind Ltd ５−ヒドロキシインド−ル−３−カルボン酸エステル化合物
DE3891468T1 (de) * 1989-01-12 1991-02-21 Vni Skij Chimiko Farmacevtices Aethylester der 6-brom-5-hydroxy-4-dimethylaminomethyl-1-methyl-2-phenylthiomethylindol-3-karbonsaeure des monohydrat-hydrogenchlorids, verfahren zu seiner herstellung und arzneipraeparat mit antiviraler, interferoniduzierender und immunomodulierender wirkung auf seiner grundlage

Also Published As

Publication number Publication date
FR2650504B1 (fr) 1993-12-24
SE9000282D0 (sv) 1990-01-26
SE9000282L (sv) 1991-07-27
DE3891468T1 (de) 1991-02-21
GB2234510A (en) 1991-02-06
GB9020370D0 (en) 1990-11-21
DE3891468C2 (de) 1994-02-24
NL9000265A (nl) 1991-09-02
FR2650504A1 (fr) 1991-02-08
BE1003341A4 (fr) 1992-03-03
US5198552A (en) 1993-03-30
GB2234510B (en) 1992-03-25
CH678726A5 (de) 1991-10-31
WO1990008135A1 (en) 1990-07-26
DK15490A (da) 1991-07-20
DK15490D0 (da) 1990-01-19

Similar Documents

Publication Publication Date Title
SE465462B (sv) 6-brom-5-hydroxi-4-dimetylaminometyl-1-metyl-2-fenyltiometylindol-3-karbonsyra etylester-hydroklorid i monohydratform, foerfarande foer framstaellning av densamma och paa hydrokloriden i monohydratform baserat laekemedelspreparat med antivirusverkan interferoninducerande och immunomodulerande verkan
AU2014224111B2 (en) Positively charged water-soluble prodrugs of 1H-imidazo[4,5-c]quinolin-4-amines and related compounds with very high skin penetration rates
EA003510B1 (ru) Ингибиторы фарнезилпротеинтрансферазы, применяемые для лечения артропатий
GB2080806A (en) Psoralens
JPH0514683B2 (de)
KR101638637B1 (ko) 알레르기성 또는 바이러스성 호흡기 질환 치료용 오스모라이트
JPH031309B2 (de)
FI89369C (fi) Foerfarande foer framstaellning av farmaceutiskt aktiv 3-l-pyroglutamoyl-l-tiazolidin-4-karboxylsyra
JPH06506212A (ja) Ｈｉｖウイルス系疾病、ヘルペス、色素性網膜炎およびマラリアの治療向けリボフラビンの利用
DE69534745T2 (de) Immunopotenzierende 5'-nucleotidase-resistente inosinmonophosphat-derivate und ihre verwendung
RU2033157C1 (ru) Средство, обладающее интерферониндуцирующей и иммуномодулирующей (иммуностимулирующей) активностью
RU2008004C1 (ru) Средство, обладающее профилактическим и лечебным действием в отношении вируса гриппа типа в
CN1477957A (zh) 用于治疗高血氨症及肝性脑病的含二氢呋喃环结构的丹参酮类化合物
JPH01265023A (ja) 下痢症ウイルス感染阻害剤
RU2454230C2 (ru) Лечение и профилактика заболеваний и инфекций свиней и домашней птицы
JPS60202822A (ja) 抗ウイルス薬
JPH01311093A (ja) 置換ｎ―グリコシルアミド類
US4049794A (en) Treatment of infections in animals
US4039656A (en) Production of attenuated viruses
JPH10504279A (ja) ウイルス感染症及び場合により炎症の予防及び／又は治療用医薬組成物並びにそれらの治療方法
RU2071323C1 (ru) Противовирусный препарат "полирем"
KR102208221B1 (ko) 신경근육질환의 예방 또는 치료용 약학적 조성물
Stogaus et al. Is oral levamisole immunostimulation in rats mediated by reduced levels of free plasma corticosterone?
JP2535633B2 (ja) エチル ６―ブロモ―５―オキシ―４―ジメチルアミノメチル―１―メチル―２―フェニルチオメチルインド―ル―３―カルボキシレ―ト ハイドロクロライド モノハイドレ―ト，その調製方法、それを含む抗ウイルス性，インタ―フェロン―誘導及び免疫変調効果を持つ薬剤の調製
CA1174169A (en) Orally active tolciclate and tolnaftate

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 9000282-5

Format of ref document f/p: F